Mia's Feed
Medical News & Research

Study Finds Women with Alzheimer’s Have Lower Levels of Healthy Fats

Study Finds Women with Alzheimer’s Have Lower Levels of Healthy Fats

Share this article

New research shows women with Alzheimer’s have lower levels of healthy fats, especially omega-3s, pointing to potential dietary strategies for prevention and management.

1 min read

Women diagnosed with Alzheimer’s disease tend to have reduced levels of beneficial fats, particularly omega-3 fatty acids, compared to healthy women. A recent study from the UK analyzed lipid profiles in men and women with and without Alzheimer’s, revealing significant differences in women’s lipid levels. Women with the disease showed decreased levels of unsaturated lipids containing omega-3s like DHA and EPA, alongside an increase in unhealthy fats. Interestingly, no similar lipid pattern was observed in men with Alzheimer’s. Researchers suggest that boosting omega-3 intake through foods such as salmon, flaxseed, and edamame may offer protective benefits for women at risk. The study emphasizes the importance of personalized approaches in Alzheimer’s research and highlights potential dietary strategies to support brain health. While more research is needed, these findings underscore the role of lipid health in cognitive decline and disease prevention.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Rice Bran Compound May Help Regulate Intestinal Movement by Inhibiting Calcium Channels

Research reveals that ferulic acid from rice bran can regulate intestinal contractions by blocking calcium channels, offering new potential treatments for gastrointestinal disorders.

Innovative Blood Test Uses Immune Protein Changes for Early Tumor Detection and Personalized Treatment Guidance

A new blood test developed by CNIO detects early-stage tumors by analyzing immune protein changes in blood, offering a promising tool for early diagnosis and personalized treatment guidance.

Texas Allocates $50 Million for Psychedelic Drug Research to Combat Addiction

Texas commits $50 million to research ibogaine, a promising psychedelic for addiction and brain injury treatment, supporting clinical trials and innovation in neurotherapy.